R: [RESADM-L] Institutional Policy on Subject Injury during research Katz, Larry 05 Oct 2007 10:26 EST

Hi Alex

I appologize for not getting back to you sooner but I am currently in Italy

You sent me some interesting emails about vacation time and grants. There are some changes in so far as charging benefit time to grants. The rules have relaxed in this area whereby it is permissable to charge time

I will tell you more when I get back

Larry

________________________________

Da: Research Administration List per conto di Schoen, Alexander
Inviato: ven 05/10/2007 10.44
A: xxxxxx@hrinet.org
Oggetto: Re: [RESADM-L] Institutional Policy on Subject Injury during research

If the injury is caused by the study drug or the "properly performed" study procedures, the costs should rest with the sponsor.  Of course, if the injury is caused by the PI or study site, then the sponsor should not have to pay.  Also - many sponsors want to carve out injuries that can be traced back to existing conditions/diseases that the patient had prior to entering the study.

You also have to watch out for lots of other language that the sponsors try to add in order to water down the section.

-----------------------------------------

Alexander Schoen

Director, Office of Sponsored Programs

Winthrop-University Hospital

222 Station Plaza North, Suite 510

Mineola, NY  11501

Phone: (516) 663-4931

Fax:     (516) 663-9718

xxxxxx@winthrop.org

-----Original Message-----
From: Research Administration List [mailto:xxxxxx@hrinet.org] On Behalf Of Espinosa, Dora
Sent: Thursday, October 04, 2007 4:55 PM
To: xxxxxx@hrinet.org
Subject: [RESADM-L] Institutional Policy on Subject Injury during research

Dear Colleagues:

I would like to know if you have an institutional policy that addresses payment to a subject for injury during research. If so, does your institution require that sponsors paid for everything, or does it allow sponsor to pay only for those expenses that are not covered by the subject's insurance or Medicare? Our institution followed the suggestion of the AAMC (Clinical Trial Contracts: A discussion of four selected Provision) in that financial responsibility for payment of treatment to trial participants resulting from an injury during the course of the trial should rest with the Sponsor. We are partnering with a local hospital and they think that our language is too strict. We are analyzing this subject again before we respond to them.

Also, do you know if hospitals are less strict than medical institutions regarding subject injury language? If yes, do you know the reason?

Dora

Dora G. Espinosa, MBA

Director

Office of Sponsored Research

Rosalind Franklin University of Medicine and Science

Ph: (847) 578-8524

Fax: (847) 775-6555

====================================================================== Instructions on how to use the RESADM-L Mailing List, including subscription information and a web-searchable archive, are available via our web site at http://www.hrinet.org (click on "Listserv Lists") ======================================================================

====================================================================== Instructions on how to use the RESADM-L Mailing List, including subscription information and a web-searchable archive, are available via our web site at http://www.hrinet.org (click on "Listserv Lists") ======================================================================

---------------------------------------------------------------------------------
The information contained in this electronic e-mail transmission
and any attachments are intended only for the use of the individual
or entity to whom or to which it is addressed, and may contain
information that is privileged, confidential and exempt from
disclosure under applicable law. If the reader of this communication
is not the intended recipient, or the employee or agent responsible
for delivering this communication to the intended recipient, you
are hereby notified that any dissemination, distribution, copying
or disclosure of this communication and any attachment is strictly
prohibited. If you have received this transmission in error, please
notify the sender immediately by telephone and electronic mail,
and delete the original communication and any attachment from any
computer, server or other electronic recording or storage device
or medium. Receipt by anyone other than the intended recipient is
not a waiver of any attorney-client, physician-patient or other
privilege. Thank you.

======================================================================
 Instructions on how to use the RESADM-L Mailing List, including
 subscription information and a web-searchable archive, are available
 via our web site at http://www.hrinet.org (click on "Listserv Lists")
======================================================================